Clinical Indication

Moderate rheumatoid arthritis.


In line with NICE TA715

Date of classification

October 2021

Review date

October 2021


Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.